Plasma proinsulin in patients with functioning pancreatic islet cell tumors.
D007516:Adenoma, Islet Cell / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000368:Aged; D000941:Antigens; D001322:Autoanalysis; D002850:Chromatography, Gel; D003981:Diazoxide / Q000494:pharmacology; D005215:Fasting; D005260:Female; D006801:Humans; D007328:Insulin / Q000096:biosynthesis / Q000097:blood; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D011384:Proinsulin / Q000097:blood*; D011863:Radioimmunoassay; D013311:Streptozocin / Q000494:pharmacology / Q000627:therapeutic use
D000941:Antigens; D007328:Insulin; D013311:Streptozocin; D011384:Proinsulin; D003981:Diazoxide